"This competition brings patients closer to one day having far better odds when contending with a AAA."
That's the lofty goal of Matthew Kuhn, co-founder and CEO of Taurus Vascular, which won the top prize at the 10th annual Texas A&M New Ventures Competition with its solution to abdominal aortic aneurysms, the Houston Chronicle reports.
The $30,000 prize went to the biotech company out of Texas A&M's Innovation Biodesign Program, which is working on a new solution to stopping abdominal aortic aneurysms before they rupture and become potentially fatal.
"This award strengthens our belief in our mission of reducing endoleak risks in endovascular aortic aneurysm repair and making a positive impact on patient care," Kuhn says in a press release.
"Fewer than 20% of patients whose AAAs rupture survive.
This competition brings patients closer to one day having far better odds when contending with a AAA."
A customized collection of grant news from foundations and the federal government from around the Web.
HootSuite CEO Ryan Holmes says “…social tools are getting more broadly adopted across organizations. It’s not just marketing anymore, it’s sales, public relations, human relations, everywhere.”